Loading…
CNS Pharmaceuticals, Inc. is projected to rise to $6.50 by 2027, a +26% move from its current price of $5.17. CNSP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.93 | $5.16 | $5.41 | -0.08% |
| Jul 14 | $4.83 | $5.16 | $5.51 | -0.16% |
| Jul 15 | $4.75 | $5.15 | $5.59 | -0.24% |
| Jul 16 | $4.69 | $5.15 | $5.65 | -0.32% |
| Jul 17 | $4.63 | $5.14 | $5.71 | -0.40% |
| Jul 18 | $4.59 | $5.14 | $5.76 | -0.48% |
| Jul 19 | $4.54 | $5.14 | $5.81 | -0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.54 | $5.14 | $5.81 | -0.56% |
| Week 2 | $4.29 | $5.11 | $6.08 | -1.12% |
| Week 3 | $4.10 | $5.08 | $6.29 | -1.67% |
| Week 4 | $3.95 | $5.05 | $6.46 | -2.22% |
| Week 5 | $3.81 | $5.02 | $6.62 | -2.77% |
| Week 6 | $3.69 | $4.99 | $6.76 | -3.32% |
| Week 7 | $3.58 | $4.97 | $6.88 | -3.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company that engages in the development of therapies for neurology and oncology diseases in the United States.
It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors.
The company was incorporated in 2017 and is headquartered in Houston, Texas.
CNS Pharmaceuticals, Inc. (CNSP) trades at $5.07, with a market cap of $7.41M, and is ranked 5062.
The current price sits against a near-term benchmark with the SMA50 at $4.73 and the SMA200 at $5.49.
The 30-day range spans $3.60 to $7.13, with a support at $3.98 and a resistance at $5.44. The sentiment is BULLISH and annualized volatility is 100%.
A major floor 58.8% below — a decisive break under it would weaken the trend.
The nearest floor, 22.9% below — buyers have tended to step in here.
The nearest ceiling, 5.3% above — a clean break opens room to run.
A major ceiling 51.8% above — clearing it would confirm fresh momentum.
Key CNSP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNSP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.19 | Sell | $5.15 | Buy |
| MA 10 | $4.86 | Buy | $4.98 | Buy |
| MA 20 | $4.69 | Buy | $4.84 | Buy |
| MA 50 | $5.01 | Buy | $4.64 | Buy |
| MA 100 | $3.83 | Buy | $5.10 | Buy |
| MA 200 | $5.40 | Sell | $172.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.80 | Neutral |
| Stoch RSI (14) | 79.18 | Neutral |
| CCI (20) | 96.14 | Neutral |
| Williams %R (14) | -16.55 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 20.40 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 83.45 | Sell |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | 0.36 | Buy |
| Ultimate (7,14,28) | 60.92 | Neutral |
| Momentum (10) | 1.01 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 5.43 | Sell |
| ADX (14) | 13.57 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day range is $3.60 to $7.13, highlighting the near-term fluctuations in price.
RSI(14) is 60, suggesting neutral to mildly bullish momentum. The short-term moving averages show the SMA50 at $4.73 and the SMA200 at $5.49, with support at $3.98 and resistance at $5.44. The overall technical tone remains bullish in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.13 | $5.17 | $6.36 | 0% | Neutral | |
| $4.83 | $6.50 | $9.41 | +26% | Bullish | |
| $5.02 | $7.11 | $10.90 | +38% | Bullish | |
| $4.51 | $6.67 | $10.70 | +29% | Bullish | |
| $4.68 | $7.19 | $11.96 | +39% | Bullish | |
| $3.98 | $6.35 | $10.91 | +23% | Bullish | |
| $3.61 | $5.97 | $10.54 | +16% | Neutral | |
| $3.86 | $6.58 | $11.92 | +27% | Bullish | |
| $4.02 | $7.09 | $13.12 | +37% | Bullish | |
| $5.14 | $9.34 | $17.68 | +81% | Bullish | |
| $3.84 | $8.09 | $16.71 | +57% | Bullish | |
| $8.28 | $18.41 | $42.34 | +256% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.13 | $5.17 | $5.89 | +0.00% |
| August 2026 | $3.85 | $4.64 | $5.79 | -10.25% |
| September 2026 | $3.94 | $4.80 | $6.10 | +3.56% |
| October 2026 | $3.80 | $4.68 | $6.04 | -2.58% |
| November 2026 | $3.60 | $4.47 | $5.84 | -4.47% |
| December 2026 | $3.84 | $4.81 | $6.36 | +7.61% |
Click any year to see its month-by-month CNSP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CNSP to range from $2.13 to $6.36 through 2026. The $5.17 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CNSP price prediction for 2027 points to an average of $6.50 (low $4.83, high $9.41) — a potential gain of +26% on today's $5.17. Momentum favours further upside here.
In 2028, CNSP is projected to trade between $5.02 and $10.90, averaging $7.11 — a potential gain of +38% from today's $5.17. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
CNS Pharmaceuticals, Inc.'s 2029 outlook centres on $6.67, within a $4.51 to $10.70 range. That is -6% versus the projected 2028 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2030, CNSP could reach as high as $11.96, with a base case around $7.19 and support toward $4.68 — roughly +39% from $5.17. Buyers look set to stay in control over this stretch.
Expect CNSP to range from $3.98 to $10.91 through 2031. The $6.35 average target implies a +23% move from current prices. That is -12% versus the projected 2030 average. Momentum favours further upside here.
The CNSP price prediction for 2032 points to an average of $5.97 (low $3.61, high $10.54) — a potential gain of +16% on today's $5.17. A consolidation phase looks the most probable path here.
In 2033, CNSP is projected to trade between $3.86 and $11.92, averaging $6.58 — a potential gain of +27% from today's $5.17. That is up +10% on the projected 2032 average. Momentum favours further upside here.
CNS Pharmaceuticals, Inc.'s 2034 outlook centres on $7.09, within a $4.02 to $13.12 range. That is up +8% on the projected 2033 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CNSP could reach as high as $17.68, with a base case around $9.34 and support toward $5.14 — roughly +81% from $5.17. Momentum favours further upside here.
Expect CNSP to range from $3.84 to $16.71 through 2040. The $8.09 average target implies a +57% move from current prices. That is -13% versus the projected 2035 average. Buyers look set to stay in control over this stretch.
The CNSP price prediction for 2050 points to an average of $18.41 (low $8.28, high $42.34) — a potential gain of +256% on today's $5.17. Momentum favours further upside here.
Investing $1,000 in CNSP today (≈ 193.610842 CNSP) could be worth
$3,564.42
+$2,564.42 (+256%) by 2050 · US Dollar
Based on the average projected CNSP price of $18.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNSPwould be worth at today's price.
$1,000 invested in CNSP on Jul 10, 2025 (≈ 91.7768 CNSP) would be worth
$474.03
-$525.97 (-52.6%) today · 0.47× · US Dollar
Based on a CNSP entry price of $10.9 vs. today's $5.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.07 | $1,018.74 | +1.9% |
| 1 month ago | $4.61 | $1,120.39 | +12.0% |
| 3 months ago | $2.18 | $2,369.27 | +136.9% |
| 6 months ago | $6.01 | $859.4 | -14.1% |
| 1 year ago | $10.9 | $474.03 | -52.6% |
| All time (5.0y) ago | $1,656,000 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNSP forecast.
Our base-case forecast reaches $10.00 around 2050.
Implied market cap at $10.00: $14.61M
The multi-year forecast shows continuing bullish sentiment across most forward years.
In 2027 the avg is $6.47 with a 27.6% ROI and bullish sentiment, and in 2028 the avg is $7.16 with a 41.1% ROI.
In 2030 the avg is $7.17 with a 41.4% ROI, and sentiment remains bullish. By 2035 the avg rises to $9.61 with an 89.6% ROI, and by 2040 the avg is $7.77 with a 53.2% ROI. The 2050 forecast is particularly strong, with an avg of $18.95 and a 273.8% ROI, and a max of $43.59. These figures reflect bullish momentum through the forecast horizon.
Note that 2026 is Neutral with an avg of $5.07 and 0% ROI. These are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows a min of $4.48, an avg of $7.17, and a max of $12.33, with a 41.4% ROI and bullish sentiment.
The forecast shows bullish sentiment in most years from 2027 onward, with several years offering double-digit ROIs (e.g., 2027 27.6%, 2028 41.1%, 2035 89.6%, 2050 273.8%). However, 2026 is Neutral with 0% ROI, and these are estimates, not guarantees.
Yes. The 2050 max forecast is $43.59, with an avg of $18.95 and a 273.8% ROI, reflecting strong long-term bullish potential.
The 2026 forecast shows an avg price of $5.07, a min of $2.13, and a max of $6.52, with 0% ROI and Neutral sentiment.
Annualized volatility is 100%.
CNS Pharmaceuticals, Inc. Community Discussion
0Share your CNS Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.